; or (B) serve an order to show cause upon the applicant in accordance with section 304(c). (5) Determination of supply In considering the factors under subsection (a) or (b), as applicable, for the purposes of registering an applicant eligible under paragraph (1) or (2) of this subsection, the Attorney General shall consider the demand from researchers for an adequate and uninterrupted supply of specific strains of marijuana and for marijuana grown pursuant to specific manufacturing processes. (6) Relation to the Single Convention on Narcotic Drugs (A) Constructive possession and control The registration of manufacturers and distributors of marijuana under paragraphs (1) and (2) shall constitute constructive possession and control by the Federal Government for the purposes of the obligations under the Single Convention on Narcotic Drugs. (B) Article 28 Article 28 of the Single Convention on Narcotic Drugs shall not be construed to prohibit, or impose additional restrictions upon, the manufacturing of marijuana that is conducted in accordance with paragraph (1) or (2), as applicable, and other applicable provisions of this title. . 4. Good manufacturing practices Not later than 180 days after the date of enactment of this Act, the National Institute for Drug Abuse shall develop and publish recommendations for good manufacturing practices for growing and producing marijuana (as defined in section 102 of the Controlled Substance Act ( 21 U.S.C. 802 ), as amended by this Act) for research. 5. Quotas Section 306(e) of the Controlled Substances Act ( 21 U.S.C. 826(e) ) is amended in the third sentence by striking exceeds the aggregate of the quotas of all registrants under this section and inserting should be increased to meet the changing medical, scientific, and industrial needs for the controlled substance . 6. Termination of interdisciplinary review process for non-NIH-funded researchers The Secretary of Health and Human Services may not— (1) reinstate the Public Health Service interdisciplinary review process